[Serum albumin levels and prognosis after commencing chronic dialysis in diabetic patients with end-stage renal failure]. 2002

Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
Department of Nephrology, Tokyo Medical University, Tokyo, Japan.

We investigated 1) the association between serum albumin levels(Alb) at the initiation of dialysis and survival after a mean follow-up period of 30.1 +/- 23.1 months following the commencement of chronic dialysis, and 2) the factors associated with hypoalbuminemia at the initiation of dialysis in diabetic patients with end-stage renal failure(ESRF). A hundred and thirty diabetic patients who were initiated on chronic dialysis in our department between January 1992 and November 2000 were studied. Alb and some variables were collected at 12, 6, 3, and 1 month before the initiation of dialysis(-12, -6, -3, -1 M), at the initiation of dialysis(0 M), and 1, 6, and 12 months after commencing chronic dialysis(1, 6, 12 M). Multivariate logistic regression analysis showed that hypoalbuminemia(less than 3 g/d/) at 0 M was significantly associated with an increase in urinary protein excretion per 1 g/day during -12 M and -1 M and total blindness due to diabetic retinopathy(Odds ratio 1.41, 8.83, p = 0.01, 0.03). Cox's proportional-hazard model demonstrated that a decrease in Alb per 1 g/dl at 0 M was significantly associated with survival(Hazard ratio 3.69, p = 0.03, adjusted age, sex, mode of dialysis, and urinary protein excretion during -12 M and -1 M). In addition, a decrease in Alb between -1 M and 0 M was significantly associated with elevated C-reactive protein at 0 M and a decrease in hematocrit between -1 M and 0 M. In conclusion, hypoalbuminemia at the initiation of dialysis, from any cause other than proteinuria, was associated with a poor prognosis after commencing chronic dialysis in diabetic ESRF patients.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
November 1975, Proceedings of the Clinical Dialysis and Transplant Forum,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 2019, PloS one,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 2007, Renal failure,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 2006, Renal failure,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 2019, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 1996, Nephron,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
July 2019, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
January 1993, Scandinavian journal of urology and nephrology,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
September 2010, Kardiologia polska,
Toshiyuki Nakao, and Hiroshi Matsumoto, and Hiromi Hidaka, and Maki Yoshino, and Yume Nagaoka, and Fumihiro Takeguchi, and Hideaki Iwasawa, and Ryo Tomaru
June 2007, Clinical and experimental nephrology,
Copied contents to your clipboard!